title: [Aldosterone antagonists--first choice in resistant hypertension].
authors.affiliation: , Burgstr. 7, D-80331, München, Deutschland. heinrich.holzgreve@t-online.de.
authors.forename: Heinrich
authors.initials: H
authors.lastname: Holzgreve
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003329:Coronary Vasospasm / Q000188:drug therapy*; D062865:Diuretics, Potassium Sparing / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use*; D000092502:Renin Inhibitors
chemical_list: D000319:Adrenergic beta-Antagonists; D062865:Diuretics, Potassium Sparing; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000092502:Renin Inhibitors
keywords: Resistant hypertension; aldosterone antagonists; differential treatment; eplerenone; spironolactone